Should all eligible patients with multiple myeloma receive autologous stem-cell transplant as part of initial treatment?

被引：10
|
作者：
Moreau, Philippe [1 ]
Rajkumar, S. Vincent [2 ]
机构：
[1] Univ Hosp Hotel Dieu, F-44093 Nantes, France
[2] Mayo Clin, Div Hematol, Rochester, MN 55905 USA
来源：
LEUKEMIA RESEARCH | 2012年 / 36卷 / 06期
关键词：
HIGH-DOSE THERAPY; STANDARD CHEMOTHERAPY; RANDOMIZED-TRIAL; DEXAMETHASONE; THALIDOMIDE; BORTEZOMIB; CONSOLIDATION; RESCUE;
D O I：
10.1016/j.leukres.2012.02.023
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：677 / 681
页数：5
相关论文
共 50 条
  • [21] Fractionated Stem Cell Infusions for Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplant
    Wood, Kevin
    Giralt, Sergio A.
    Koehne, Guenther
    Chung, David
    Hassoun, Hani
    Lendvai, Nikoletta
    Lesokhin, Alexander
    Hoover, Elizabeth
    Devlin, Sean
    Landau, Heather
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S192 - S192
  • [22] The role of autologous stem-cell transplantation in multiple myeloma in 2021
    Mina, Roberto
    Gay, Francesca
    CURRENT OPINION IN ONCOLOGY, 2021, 33 (06) : 642 - 647
  • [23] Fractionated Stem Cell Infusions for Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplant
    Wood, Kevin
    Giralt, Sergio A.
    Koehne, Guenther
    Chung, David
    Lendvai, Nikoletta
    Hassoun, Hani
    Lesokhin, Alex
    Hoover, Elizabeth
    Devlin, Sean
    Landau, Heather
    BLOOD, 2012, 120 (21)
  • [24] Autologous Stem-Cell Transplantation for Multiple Myeloma AUTHORS REPLY
    Harousseau, Jean-Luc
    Moreau, Philippe
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (11): : 1119 - 1119
  • [25] Autologous stem-cell transplantation and maintenance therapy for transplant-eligible multiple myeloma patients: cost-effectiveness analysis based on a network meta-analysis
    Wu, Weijia
    Wang, Yannan
    Lou, Yingting
    Fan, Xiaoyuan
    Yang, Wenqianzi
    Tang, Fengyuan
    Zhao, Zixuan
    Dong, Hengjin
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2025,
  • [26] The efficacy of Salvage Autologous Stem Cell Transplant for Patients With Multiple Myeloma Who Received Maintenance Therapy Post an Initial Transplant
    King, Justin
    Fiala, Mark
    Kohnen, Daniel
    Stockerl-Goldstein, Keith
    Wildes, Tanya
    Vij, Ravi
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E70 - E71
  • [27] Autologous stem cell transplant in patients with multiple myeloma, experience of 9 years
    Jaramillo, Francisco
    Useche, Elena
    Garcia, Juan
    Rosales, Maria
    Manzi, Eliana
    Estacio, Mayra
    Rosales, Joaquin
    REVISTA COLOMBIANA DE CANCEROLOGIA, 2018, 22 (04): : 138 - 142
  • [28] The Efficacy of Salvage Autologous Stem Cell Transplant for Patients with Multiple Myeloma Who Received Maintenance Therapy Following Initial Transplant
    King, Justin A.
    Fiala, Mark A.
    Kohnen, Daniel R.
    Wildes, Tanya M.
    Stockerl-Goldstein, Keith
    Vij, Ravi
    BLOOD, 2016, 128 (22)
  • [29] Outcomes after Autologous Stem Cell Transplant in Patients with Relapsed Multiple Myeloma
    Lemieux, Christopher
    Craig, Juliana
    Iberri, David
    Arai, Sally
    Johnston, Laura J.
    Lowsky, Robert
    Muffly, Lori S.
    Shiraz, Parveen
    Liedtke, Michaela
    Rezvani, Andrew R.
    Frank, Matthew J.
    Weng, Wen-Kai
    Meyer, Everett H.
    Shizuru, Judith A.
    Negrin, Robert S.
    Miklos, David B.
    Sidana, Surbhi
    BLOOD, 2020, 136
  • [30] Autologous stem cell transplant for multiple myeloma patients 70 years or older
    Muchtar, E.
    Dingli, D.
    Kumar, S.
    Buadi, F. K.
    Dispenzieri, A.
    Hayman, S. R.
    Wolf, R. C.
    Gastineau, D. A.
    Chakraborty, R.
    Hogan, W. J.
    Leung, N.
    Kapoor, P.
    Lacy, M. Q.
    Rajkumar, S. V.
    Gertz, M. A.
    BONE MARROW TRANSPLANTATION, 2016, 51 (11) : 1449 - 1455
12345